Fuji Kyuko Co., Ltd. (TYO:9010)
Japan · Delayed Price · Currency is JPY 2,170.00
+20.00 (0.93%)
Aug 6, 2025, 3:30 PM JST
ShockWave Medical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 52,230 | 50,701 | 42,924 | 35,083 | 30,451 | Upgrade | |
Revenue Growth (YoY) | 3.02% | 18.12% | 22.35% | 15.21% | -41.77% | Upgrade |
Cost of Revenue | 42,497 | 41,089 | 37,407 | 33,044 | 32,443 | Upgrade |
Gross Profit | 9,733 | 9,612 | 5,517 | 2,039 | -1,992 | Upgrade |
Selling, General & Admin | 1,340 | 1,375 | 1,171 | 1,165 | 989 | Upgrade |
Other Operating Expenses | 25 | 30 | 25 | 22 | 25 | Upgrade |
Operating Expenses | 1,419 | 1,460 | 1,274 | 1,278 | 1,184 | Upgrade |
Operating Income | 8,314 | 8,152 | 4,243 | 761 | -3,176 | Upgrade |
Interest Expense | -458 | -449 | -452 | -464 | -475 | Upgrade |
Interest & Investment Income | 151 | 113 | 95 | 80 | 77 | Upgrade |
Earnings From Equity Investments | 37 | 13 | 15 | 29 | -24 | Upgrade |
Other Non Operating Income (Expenses) | 79 | 106 | 104 | 82 | 182 | Upgrade |
EBT Excluding Unusual Items | 8,123 | 7,935 | 4,005 | 488 | -3,416 | Upgrade |
Gain (Loss) on Sale of Investments | 41 | 5 | 63 | 190 | 28 | Upgrade |
Gain (Loss) on Sale of Assets | 33 | 4 | 12 | 8 | 2 | Upgrade |
Asset Writedown | -1,265 | -2,007 | -849 | -470 | -1,218 | Upgrade |
Other Unusual Items | 665 | 662 | 430 | 506 | 875 | Upgrade |
Pretax Income | 7,597 | 6,599 | 3,661 | 722 | -3,729 | Upgrade |
Income Tax Expense | 2,385 | 1,914 | 1,284 | 338 | -944 | Upgrade |
Earnings From Continuing Operations | 5,212 | 4,685 | 2,377 | 384 | -2,785 | Upgrade |
Minority Interest in Earnings | -105 | -114 | -59 | -8 | -1 | Upgrade |
Net Income | 5,107 | 4,571 | 2,318 | 376 | -2,786 | Upgrade |
Net Income to Common | 5,107 | 4,571 | 2,318 | 376 | -2,786 | Upgrade |
Net Income Growth | 11.73% | 97.20% | 516.49% | - | - | Upgrade |
Shares Outstanding (Basic) | 53 | 53 | 53 | 53 | 53 | Upgrade |
Shares Outstanding (Diluted) | 53 | 53 | 53 | 53 | 53 | Upgrade |
Shares Change (YoY) | - | -0.00% | 0.00% | -0.01% | -0.01% | Upgrade |
EPS (Basic) | 96.18 | 86.09 | 43.65 | 7.08 | -52.46 | Upgrade |
EPS (Diluted) | 96.18 | 86.09 | 43.65 | 7.08 | -52.46 | Upgrade |
EPS Growth | 11.73% | 97.20% | 516.48% | - | - | Upgrade |
Free Cash Flow | 4,129 | 6,900 | 3,831 | 1,865 | -1,632 | Upgrade |
Free Cash Flow Per Share | 77.76 | 129.95 | 72.15 | 35.12 | -30.73 | Upgrade |
Dividend Per Share | 29.000 | 26.000 | 15.000 | 10.000 | 6.000 | Upgrade |
Dividend Growth | 11.54% | 73.33% | 50.00% | 66.67% | -60.00% | Upgrade |
Gross Margin | 18.63% | 18.96% | 12.85% | 5.81% | -6.54% | Upgrade |
Operating Margin | 15.92% | 16.08% | 9.88% | 2.17% | -10.43% | Upgrade |
Profit Margin | 9.78% | 9.02% | 5.40% | 1.07% | -9.15% | Upgrade |
Free Cash Flow Margin | 7.90% | 13.61% | 8.92% | 5.32% | -5.36% | Upgrade |
EBITDA | 13,828 | 13,776 | 9,748 | 6,756 | 3,599 | Upgrade |
EBITDA Margin | 26.47% | 27.17% | 22.71% | 19.26% | 11.82% | Upgrade |
D&A For EBITDA | 5,514 | 5,624 | 5,505 | 5,995 | 6,775 | Upgrade |
EBIT | 8,314 | 8,152 | 4,243 | 761 | -3,176 | Upgrade |
EBIT Margin | 15.92% | 16.08% | 9.88% | 2.17% | -10.43% | Upgrade |
Effective Tax Rate | 31.39% | 29.00% | 35.07% | 46.81% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.